Truenat™ HCV RNA Assay Evaluation

NACompletedINTERVENTIONAL
Enrollment

1,330

Participants

Timeline

Start Date

January 12, 2020

Primary Completion Date

July 20, 2021

Study Completion Date

July 20, 2021

Conditions
Hepatitis C
Interventions
DEVICE

Molbio Truenat™ HCV assay (the investigational product)

The Molbio Truenat™ HCV assay (the investigational product) is a quantitative chip-based Real Time Reverse Transcription Polymerase Chain Reaction (qRT-PCR) tests for the detection of HCV genomic RNA from human whole blood, EDTA plasma and serum. The Truenat™ HCV assay runs on the Truelab™ Uno, Truelab™ Duo or Truelab™ Quadro Dx. Results of testing by Truenat™ HCV assay will not be used to make any clinical decisions, and should not be communicated to study participants.

OTHER

Abbott RealTime HCV assay

Plasma specimens will be also tested on Abbott RealTime HCV assay that is approved for HCV diagnostics use by countries' authorities. Only the results of Abbott RealTime HCV assay may be used to make clinical decisions.

Trial Locations (5)

8200

Aarhus University Hospital, Aarhus

10330

HIV-NAT Thai Red Cross AIDS Research Centre, Bangkok

Unknown

St Paul's Hospital Millennium Medical College, Addis Ababa

National Centre for Diseases Control, Tbilisi

03150

International Charitable Foundation Alliance for Public Health, Kyiv

All Listed Sponsors
lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER

NCT04236973 - Truenat™ HCV RNA Assay Evaluation | Biotech Hunter | Biotech Hunter